News Mainstay Medical International Irish S.E.

Equities

MSTY1

IE00BJYS1G50

Delayed Irish S.E. Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		+6.44%	-38.57%

Mar. 12	Mainstay Medical Holdings plc Announces Publication of Clinical Results Comparing Older Patients and Younger Patients	CI
Feb. 26	Mainstay Medical Holdings plc announced that it has received ?115 million in funding from a group of investors	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mainstay Medical Holdings plc Announces Publication of Clinical Results Comparing Older Patients and Younger Patients	Mar. 12	CI
Mainstay Medical Holdings plc announced that it has received ?115 million in funding from a group of investors	Feb. 25	CI
Mainstay Medical Holdings plc announced that it expects to receive funding	Feb. 22	CI
Mainstay Medical Announces Receipt of FDA Approval for MRI Labeling on Reactiv8® Restorative Neurostimulation Systemtm	Feb. 12	CI
Mainstay Medical Announces Completion of Enrollment of RESTORE Clinical Trial of ReActiv8® in the United States	23-08-29	CI
Mainstay Medical Holdings plc Announces Publication of Three-Year Clinical Trial Data from Post-Market Clinical Follow-Up Registry of Reactiv8 in the United Kingdom	23-07-20	CI
Mainstay Medical Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-27	CI
Mainstay Medical Holdings plc Announces the Publication of Effect of Restorative Neurostimulation on Major Drivers of Chronic Low Back Pain Economic Impact	23-03-02	CI
Mainstay Medical Announces Publication of Post-Market Clinical Trial Data from Ongoing ReActiv8®-C Study in Chronic Low Back Pain Patients	22-11-22	CI
Mainstay Medical Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-28	CI
Mainstay Medical Holdings plc Announces Publication of Two-Year Patient Outcomes Data from Reactiv8-B Clinical Trial Demonstrating Long-Term Efficacy of Reactiv8 Restorative Neurostimulation	22-01-06	CI
Mainstay Medical Holdings plc Announces Appointment of Jeffrey Dunn and Eric Major to Its Board of Directors	21-12-14	CI
Mainstay Medical Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2020	21-07-09	CI
Mainstay Medical Announces Limited Announces Commercial Launch of ReActiv8® in US	21-06-29	CI
Oxford Finance LLC Announces Closing of $50 Million Senior Secured Term Loan with Mainstay Medical Holdings plc	21-04-20	CI
Mainstay Medical Announces Commercial Launch of ReActiv8® in Australia	21-03-08	CI
Mainstay Medical Holdings plc announced that it has received $108 million in funding from Ally Bridge Group, KCK Group, Sofinnova Partners SAS, Fountain Healthcare Partners, and another investor	21-02-15	CI
Mainstay Medical Holdings plc announced a financing transaction	21-02-08	CI
Mainstay Medical Holdings plc Announces U.S. FDA Approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain	20-06-22	CI
Mainstay Medical : announces Scheme becoming effective	20-06-05	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Mainstay Medical International Irish S.E.

Equities

MSTY1

IE00BJYS1G50

Summary

Filters